Early stage biotech; pre-clinical therapeutic; diagnostic; medical device companies
Calling all early stage biotech; pre-clinical therapeutic; diagnostic; medical device companies!
Portal Innovations is a venture capital firm that helps exceptional life sciences innovators build their companies where they live. They surround these entrepreneurs with the resources and community they need: seed capital, fully equipped lab space, and expertise and introductions to other investors and partners.
LaunchBio and Silicon Valley Bank, a division of First Citizens Bank, are pleased to announce their next Investor Connect virtual event with Portal Innovations.
Applications will be selected based on meeting the following criteria:
A presence in or near Portal’s locations – Atlanta, Boston, Chicago, and Houston
Early-stage biotech companies developing therapeutics, diagnostics, or medical devices.
- Asset-focused therapeutic companies with strong in vivo data, to fund hit-to-lead and IND-enabling studies.
- Platform-focused therapeutic companies with disruptive technology, to validate and expand platforms and nominate lead assets.
- Diagnostic and medical device companies addressing large unmet medical needs and markets with strong in vivo data, to fund design, manufacturing, and clinical testing.
Seed rounds are the sweet spot, but also companies seeking pre-seed, seed, and series A funding.
Qualifying start-ups can apply here today. Applications are accepted on a rolling basis.
Learn more about LaunchBio’s Investor Connect series, in partnership with Silicon Valley Bank, a division of First Citizens Bank.